- Home
- SLQT vs NRXP Comparison
SLQT vs NRXP Comparison
Compare SLQT & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLQT | NRXP |
|---|---|---|
| Founded | 1999 | 2015 |
| Country | United States | United States |
| Employees | N/A | 29 |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.6M | 181.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | SLQT | NRXP |
|---|---|---|
| Price | $0.65 | $3.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $2.88 | ★ $38.25 |
| AVG Volume (30 Days) | ★ 1.9M | 784.5K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 105.00 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $1,526,594,000.00 | N/A |
| Revenue This Year | $10.97 | $2,547.84 |
| Revenue Next Year | $6.14 | $1,591.73 |
| P/E Ratio | $6.29 | ★ N/A |
| Revenue Growth | ★ 15.50 | N/A |
| 52 Week Low | $0.56 | $1.65 |
| 52 Week High | $2.77 | $5.06 |
Technical Indicators
Market Signals| Indicator | SLQT | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 44.81 |
| Support Level | $0.56 | $2.90 |
| Resistance Level | $0.94 | $4.20 |
| Average True Range (ATR) | 0.05 | 0.32 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 1.04 | 0.95 |
Price Performance
Historical ComparisonAbout SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.